Hutchison China MediTech Limited HCM
$ 17.68
-1.56%
Annual report 2023
added 11-16-2024
Hutchison China MediTech Limited Balance Sheet 2011-2024 | HCM
Annual Balance Sheet Hutchison China MediTech Limited
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -206 M | -91.1 M | -59.3 M | - | -32.6 M | 18.1 M | 14.3 M | 4.64 M | -23.9 M | -23.7 M | ||
Long Term Debt |
48.2 M | 18.1 M | - | 26.9 M | 26.8 M | 26.7 M | - | 26.8 M | 26.9 M | 26.9 M | - | 26.9 M | - |
Long Term Debt Current |
- | - | - | 2.78 M | 3.22 M | - | 30 M | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 46.8 M | 32.8 M | 27.6 M | 1.12 M | 35 M | 46.4 M | 29.9 M | 2.4 M | 44.7 M | 29 M |
Total Current Liabilities |
403 M | 354 M | 312 M | 158 M | 113 M | 85.5 M | 105 M | 95.1 M | - | - | - | - | - |
Total Liabilities |
536 M | 393 M | 333 M | 205 M | 152 M | 120 M | 94.5 M | 138 M | 127 M | 99.1 M | 80.8 M | 126 M | 117 M |
Deferred Revenue |
57.6 M | 13.3 M | 12.3 M | 1.6 M | 2.11 M | 2.54 M | 18.2 M | 962 K | 1.17 M | 564 K | 3.12 M | - | - |
Retained Earnings |
-871 M | -971 M | -610 M | -416 M | -290 M | -183 M | - | - | -92 M | -69.2 M | -74.4 M | -90 M | -93.8 M |
Total Assets |
1.28 B | 1.03 B | 1.37 B | 724 M | 465 M | 532 M | 209 M | 342 M | 230 M | 219 M | 186 M | 209 M | 195 M |
Cash and Cash Equivalents |
- | - | - | 236 M | 121 M | 86 M | 85.3 M | 79.4 M | 31.9 M | 38.9 M | - | - | - |
Book Value |
743 M | 637 M | 1.04 B | 519 M | 313 M | 412 M | 114 M | 204 M | 102 M | 120 M | 105 M | 83.6 M | 77.3 M |
Total Shareholders Equity |
731 M | 610 M | 1.04 B | 519 M | 313 M | 412 M | 484 M | 184 M | 102 M | 56.9 M | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Hutchison China MediTech Limited
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | 7.16 M | - | 26.9 M | - | 26.9 M | - | 26.8 M | - | 26.8 M | - | - | 26.8 M | 26.7 M | - | 26.7 M | - | 30 M | - | 20 M | - | 26.8 M | - | - | - | 26.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 333 M | - | 259 M | - | 205 M | - | 159 M | - | 152 M | 116 M | 122 M | 139 M | 120 M | - | 120 M | - | 113 M | - | 133 M | - | 138 M | - | - | - | 127 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | 12.3 M | - | - | - | 1.6 M | - | - | - | 2.11 M | - | - | - | 2.54 M | - | 3.75 M | - | 1.3 M | - | - | - | 962 K | - | - | - | 1.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | -610 M | - | -518 M | - | -416 M | - | -340 M | - | -290 M | -260 M | -229 M | -204 M | -183 M | - | -141 M | - | -107 M | - | -78.7 M | - | -80.4 M | - | - | - | -92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | 1.37 B | - | 1.27 B | - | 724 M | - | 526 M | - | 465 M | 454 M | 495 M | 539 M | 532 M | - | 578 M | - | 598 M | - | 345 M | - | 342 M | - | - | - | 230 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | 378 M | - | 587 M | - | 236 M | - | 49.9 M | - | 121 M | 97.1 M | 83.4 M | 91.7 M | 86 M | 116 M | 75.3 M | 78.1 M | 85.3 M | - | 113 M | - | 79.4 M | - | 76 M | - | 31.9 M | - | - | - | 38.9 M | - | - | - | 46.9 M | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | 1.04 B | - | 1.01 B | - | 519 M | - | 367 M | - | 313 M | 338 M | 373 M | 400 M | 412 M | - | 458 M | - | 485 M | - | 212 M | - | 204 M | - | - | - | 102 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | 987 M | - | 985 M | - | 484 M | - | 342 M | - | 288 M | 314 M | 348 M | 376 M | 389 M | 425 M | 432 M | 478 M | 462 M | - | 189 M | - | 184 M | - | 199 M | - | 83.4 M | - | - | - | 56.9 M | - | - | - | 78.1 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency